{"date":"2025-05-22","count":16,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7427-2025-05-22-1902-ixu9js","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-22","time":"19:02:20","subject":"公告華上生醫自主開發具免疫調控活性的多重激酉每抑制劑抗癌候選新藥GNTbm-TKI，經審查取得南非發明專利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-05-22 19:02，「公告華上生醫自主開發具免疫調控活性的多重激酉每抑制劑抗癌候選新藥GNTbm-TKI，經審查取得南非發明專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-05-22-1758-dnlzoh","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-05-22","time":"17:58:08","subject":"公告本公司114年第一次現金增資發行新股認股基準日等相關事宜(補充公告代收股款及存儲專戶行庫)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-05-22 17:58，「公告本公司114年第一次現金增資發行新股認股基準日等相關事宜(補充公告代收股款及存儲專戶行庫)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-05-22-1737-182uyqk","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-05-22","time":"17:37:06","subject":"公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOATE SALTS」歐洲專利核准通知書。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-05-22 17:37，「公告本公司收到「LONG-ACTING INJECTABLE FORMULATIONSOF KETAMINE PAMOA」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-05-22-1731-ds864w","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-05-22","time":"17:31:46","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-05-22 17:31，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6620-2025-05-22-1713-1glnufr","company_id":"6620","company":"漢達","market":"上櫃","industry":"生技醫療","date":"2025-05-22","time":"17:13:47","subject":"代子公司Handa Pharmaceuticals, LLC公告戒菸輔助劑HND-032通過美國FDA學名藥藥證申請審查，取得最終核准(Final Approval)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：漢達（6620），2025-05-22 17:13，「代子公司Handa Pharmaceuticals, LLC公告戒菸輔助劑HND-032通過美國FDA學名藥藥證申請審查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7808-2025-05-22-1713-1ui99op","company_id":"7808","company":"訊聯智藥","market":"興櫃","industry":"生技醫療","date":"2025-05-22","time":"17:13:30","subject":"因應本公司興櫃，依法委託簽證會計師出具內控專審報告","clause":"第25款","fact_date":"2025-05-22","cite_as":"公開資訊觀測站重大訊息：訊聯智藥（7808），2025-05-22 17:13，「因應本公司興櫃，依法委託簽證會計師出具內控專審報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-05-22-1643-9bwaif","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-05-22","time":"16:43:04","subject":"公告本公司「製造自體交聯透明質酸凝膠之方法及其產物」取得日本專利","clause":"第51款","fact_date":"2025-05-22","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-05-22 16:43，「公告本公司「製造自體交聯透明質酸凝膠之方法及其產物」取得日本專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-05-22-1559-c4ztqc","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-05-22","time":"15:59:45","subject":"公告本公司114年股東常會決議通過解除董事競業禁止之限制案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-05-22 15:59，「公告本公司114年股東常會決議通過解除董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-05-22-1552-metrbb","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-05-22","time":"15:52:35","subject":"公告本公司私募普通股收足股款暨調整增資基準日","clause":"第53款","fact_date":"2025-05-22","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-05-22 15:52，「公告本公司私募普通股收足股款暨調整增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2025-05-22-1535-ds864w","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2025-05-22","time":"15:35:45","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-05-22","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2025-05-22 15:35，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-05-22-1525-1nsksc0","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-05-22","time":"15:25:53","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解","clause":"第53款","fact_date":"2025-05-22","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-05-22 15:25，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-05-22-1520-ds864w","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-05-22","time":"15:20:01","subject":"公告本公司114年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-05-22 15:20，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-05-22-1518-1yqb19o","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-05-22","time":"15:18:43","subject":"公告本公司除息基準日及相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-05-22 15:18，「公告本公司除息基準日及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-05-22-1215-1fqkmsr","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-05-22","time":"12:15:16","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-05-22 12:15，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4735-2025-05-22-1035-1xp2etp","company_id":"4735","company":"豪展","market":"上櫃","industry":"生技醫療","date":"2025-05-22","time":"10:35:24","subject":"公告本公司董事長訂定民國114年第1季盈餘之除息基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：豪展（4735），2025-05-22 10:35，「公告本公司董事長訂定民國114年第1季盈餘之除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4743-2025-05-22-0639-i67mro","company_id":"4743","company":"合一","market":"上櫃","industry":"生技醫療","date":"2025-05-22","time":"06:39:35","subject":"本公司Fespixon新藥以顯著臨床療效執行藥事經濟學分析，顯示在新加坡醫療情境下，具有成本節約藥事經濟優勢，獲國際知名SCI期刊Diabetes, Obesity and Metabolism接受並向國際發表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合一（4743），2025-05-22 06:39，「本公司Fespixon新藥以顯著臨床療效執行藥事經濟學分析，顯示在新加坡醫療情境下，具有成本節約藥事經濟優勢，獲國際知名」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}